Atai life sciences to participate in upcoming september investor conferences

New york and berlin, sept. 06, 2023 (globe newswire) -- atai life sciences (nasdaq: atai) (“atai”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, will participate in upcoming september investor conferences.
ATAI Ratings Summary
ATAI Quant Ranking